What Paragon Ventures does

Paragon Ventures is a privately-held boutique M&A advisory firm founded in 1994 and headquartered in Wayne, Pennsylvania, specializing exclusively in the merger, acquisition, and divestiture of private mid-market healthcare companies. The firm operates as Paragon Ventures, LLC and serves a dual-sided market: healthcare business owners seeking to sell or recapitalize, and corporate buyers plus private equity investors seeking acquisition targets across 14 healthcare sub-sectors including behavioral health, home health, hospice, infusion therapy, medical devices, pharmacy, telehealth, and urgent care. Its core technology stack is minimal — the firm relies on a proprietary Market Pulse transaction database and a 6,000+ buyer/investor relationship database as its primary differentiating assets, alongside senior human advisory expertise.

The firm's service portfolio spans the full M&A lifecycle: pre-market strategic planning and exit strategy development, business valuations via its proprietary Market Pulse Analysis, confidential controlled sale processes through "The Paragon Process," and ongoing advisory via its Private Client Group tier. Revenue is generated through professional services fees — primarily success-based advisory fees on closed transactions, supplemented by valuation engagements and retainer-based Private Client Group relationships. Marketing and lead generation is conducted through sector-specific website content, a Market Pulse newsletter, educational seminars, and direct relationship-driven outreach, with all leads converging on a single phone line (800-719-1555) or private conference scheduling.

In February 2026 the firm announced PV AiX, an AI-supported, human-curated extension of its advisory offering, signaling an early-stage move toward technology-augmented deal support. The firm has no disclosed institutional ownership or external private equity backing, and revenue figures are not publicly reported; it appears to be founder/management-owned, led by President and Founder Marc S. Rose alongside senior advisors including Scott Fife and April Stone.

Name

Paragon Ventures

Legal name

Paragon Ventures, LLC

Website

https://paragonventures.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

Paragon Ventures is a Wayne, Pennsylvania-based boutique M&A advisory firm founded in 1994 that exclusively facilitates mergers, acquisitions, and divestitures of private mid-market healthcare companies across 14 sub-sectors, serving owners, strategic buyers, and private equity investors.

Ownership category

akta.pro rank

Product category

Healthcare M&A Advisory

NAICS

Miscellaneous Intermediation (52391)

SIC

Services-Management Services (8741)

akta.pro primary industry

Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG)

akta.pro secondary industries

Divestitures, Carve-Outs & Spin-Off Advisory (FSAEAGAL), Divestitures, Spin-offs & Carve-outs Advisory (BPAHADAJ)

Keywords

• Healthcare M&A advisory
• Mergers and acquisitions
• Business valuations
• Exit strategies
• Private equity advisory

Headquarters

HQ city

Wayne

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. M&A Advisory Services: Paragon Ventures generates revenue through providing merger, acquisition, and divestiture advisory services to healthcare companies. Their services span from strategic planning through valuation, execution, and closing. Revenue is generated through advisory fees, likely including success fees upon transaction completion based on industry standard M&A advisory practices.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Paragon Ventures provides merger, acquisition and divestiture advisory services for private mid-market healthcare companies, including buy-side and sell-side representation, strategic planning, business valuations using its proprietary Market Pulse Analysis, a Private Client Group for ongoing valuation monitoring, and the confidential Paragon Process that takes transactions from initial strategic planning through execution and closing.

Product overview

Paragon Ventures operates as a single unified advisory platform offering healthcare M&A advisory services rather than a modular software product. The core offering is comprehensive merger and acquisition advisory for private mid-market healthcare companies, supported by ancillary services including the Private Client Group (premium ongoing advisory), Strategic Planning & Exit Strategies, Business Valuations with Market Pulse Analysis, and the Paragon Process methodology. The firm also provides a proprietary Market Pulse database tracking healthcare M&A transactions, plus buyer and seller toolkits for transaction participants. Most recently, the firm announced PV AiX, an AI-supported advisory service combining artificial intelligence with human curation for M&A analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare M&A Advisory Services Comprehensive merger, acquisition and divestiture advisory for private mid-market healthcare companies, covering buy-side and sell-side representation, strategic planning, valuations, confidential marketing, negotiation and closing, aimed at healthcare business owners and corporate/PE buyers.
• Private Client Group Premium ongoing service for private healthcare business owners providing continuous market valuation monitoring, strategic guidance, and pre-sale preparation intended to maximize eventual transaction value.
• Strategic Planning & Exit Strategies Pre-market strategic planning service that helps healthcare business owners prepare their company for sale and improve sales price and transaction terms.
• Business Valuations with Market Pulse Analysis Pre-market business valuation service for healthcare companies that uses Paragon's exclusive Market Pulse Analysis to confirm enterprise value and identify performance elements that enhance or detract from valuation.
• The Paragon Process Paragon's exclusive, confidential and controlled M&A process that creates the structured methodology for buying or selling private mid-market healthcare companies.
• PV AiX AI-supported, human-curated healthcare M&A advisory service that combines artificial intelligence capabilities with expert human analysis to support merger and acquisition activities in the healthcare sector.
• Market Pulse Proprietary database and reporting system that tracks healthcare M&A transactions and market activity and publishes market intelligence for healthcare M&A participants.
• Buy A Business (Buy-Side Advisory) Buy-side advisory service for healthcare strategic buyers and private equity sponsors seeking acquisitions, providing listings access, buyer profile registration, and acquisition advisory through closing.
• Buyer Toolkit Resource and advisory toolkit for prospective healthcare buyers including buyer profile registration and acquisition criteria development support.
• Seller Toolkit Resource and advisory toolkit for healthcare business owners preparing to sell, including client profile registration and the Paragon Process documentation.
• Private Equity Options Advisory service exploring private equity recapitalizations and partial or full exit options as an alternative to a traditional sale, structured for healthcare business owners evaluating capital structure alternatives.

Quantifiable outcome

• Paragon has facilitated successful healthcare M&A transactions across multiple sectors including infusion therapy, medical equipment, behavioral health, and home health

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Provident Healthcare Partners: Boutique M&A advisory firm exclusively focused on healthcare, covering many of the same mid-market sub-sectors (behavioral health, home health, pharmacy, physician services) as Paragon Ventures. Closest direct competitor in size, scope, and healthcare-only positioning.
• Edgemont Partners: Healthcare-focused M&A advisory boutique serving middle-market companies, with sector coverage and deal sizes closely aligned to Paragon's mid-market healthcare focus. Direct competitor for the same seller and buyer universe.
• Cain Brothers (KeyBanc Capital Markets): Specialist healthcare investment bank (now part of KeyBanc) covering M&A, capital raising, and merchant banking across the healthcare services and products spectrum. A scaled direct peer in the healthcare M&A sub-vertical.
• VMG Health: Healthcare-specialized valuation and M&A advisory firm providing transaction advisory, fairness opinions, and consulting to healthcare providers and investors. Overlaps with Paragon's Private Client Group and business valuation services.
• McBee Associates: Healthcare-focused advisory firm providing M&A, valuation, and strategic consulting to mid-market healthcare companies, particularly in physician services and ancillary sectors. A niche direct peer competing for similar transactions.

Broad incumbents

• Houlihan Lokey: Global investment bank with a dedicated healthcare M&A practice spanning middle-market and large-cap transactions. Competes with Paragon for the larger end of the mid-market healthcare M&A universe with materially greater resources and reach.
• Jefferies Healthcare Group: Diversified investment bank with an active healthcare services and technology M&A franchise, serving both mid-market and large-cap healthcare clients. A broad incumbent competing for some of the same sell-side mandates.
• Deloitte Corporate Finance (Deloitte M&A Services): Big Four M&A advisory practice with significant healthcare sector coverage, including middle-market healthcare transactions. Competes for healthcare mid-market sell-side and buy-side mandates with greater geographic and resource scale.
• KPMG Corporate Finance: Big Four M&A advisory practice active in U.S. healthcare mid-market transactions, providing sell-side, buy-side, and valuation services. A broad incumbent competitor in the healthcare M&A ecosystem.

Emerging players

• Hampleton Partners: Technology-focused M&A advisory boutique with growing healthcare IT and digital health coverage. Adjacent emerging competitor in the healthcare IT and telehealth sub-sectors where Paragon is also active.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/jmsadock

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Paragon Ventures